Previous close | 28.80 |
Open | 28.93 |
Bid | 29.00 x 100 |
Ask | 29.08 x 100 |
Day's range | 28.89 - 29.34 |
52-week range | 19.80 - 35.50 |
Volume | |
Avg. volume | 808,232 |
Market cap | 1.631B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Agios Pharmaceuticals Inc (NASDAQ:AGIO), a biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of cancer and rare genetic diseases, has seen a recent insider transaction according to the latest SEC filings.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript February 15, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to the Agios Fourth Quarter 2023 Earnings Conference Call. At this time, all […]